Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04221490 · ClinicalTrials.gov registry record · NA
2019-06 TRISCEND Study
A NA study of Cardiovascular Diseases and Heart Valve Diseases, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 228
- Enrollment target
- 20
- Study locations
NCT04221490 is a NA study of Cardiovascular Diseases and Heart Valve Diseases that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 228 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT04221490, a NA study of Cardiovascular Diseases and Heart Valve Diseases, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Conditions Studied
Interventions
- DEVICE Transcatheter Tricuspid Valve Replacement
Study Locations (20)
Other
- Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval (IUCPQ-ULaval) - Québec
- CHU Bordeaux, Hôpital Cardiologique Haut Lévêque - Pessac
- Clinique Pasteur - Toulouse
- InselSpital University Hospital Bern - Bern
California
- Cedars-Sinai Medical Center - Los Angeles
- Stanford University - Stanford
Georgia
- Emory University - Atlanta
- Piedmont Heart Institute - Atlanta
Massachusetts
- Massachusetts General Hospital Boston - Boston
- Brigham and Women's Hospital - Boston
New York
- Columbia University Irving Medical Center / NYPH - New York
- Montefiore Medical Center - The Bronx
Illinois
- Northwestern University - Evanston
Michigan
- Henry Ford Hospital - Detroit
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2020-05-06 |
| Est. Completion | 2029-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04221490
The ClinicalTrials.gov registry entry for NCT04221490 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Transcatheter Tricuspid Valve Replacement is the first listed.
NCT04221490 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Other, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT04221490 about?
NCT04221490 is a clinical study titled "2019-06 TRISCEND Study". Prospective, multi-center study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
What is the current status of trial NCT04221490?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 228 participants. The study started on 2020-05-06. Estimated completion is 2029-01-31.
What conditions does trial NCT04221490 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Valve Diseases, Tricuspid Valve Regurgitation.
What interventions are being tested in trial NCT04221490?
The interventions under investigation include: Transcatheter Tricuspid Valve Replacement (DEVICE).
Who is sponsoring clinical trial NCT04221490?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04221490 being conducted?
This trial has 20 study locations across California, Georgia, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.